Oslo, 17 April 2018 – Reference is made to the stock exchange notice of 12 April 2018 by PCI Biotech Holding ASA (the “Company”) in respect of the issuance of 8,000 new shares following exercise of employee share options in the Company.
The share capital increase resolved by the Board of Directors following the share option exercise on 12 April 2018, has now been registered in the Norwegian Register of Business Enterprises, and the capital increase has thus been completed.
The Company’s new share capital is NOK 74,984,670 divided by 24,994,890 shares, each with a nominal value of NOK 3.00 and each giving one vote at the Company’s general Meeting.
The new shares issued following the share option exercise will be tradable when they have been registered on the VPS accounts of the subscriber; such registration is expected to be executed on or about 18 April 2018.
For further information, please contact:
Ronny Skuggedal, CFO
Mobile: +47 9400 5757